Jammu, June 6: As part of its One Week One Lab (OWOL) Campaign, CSIR-Indian Institute of Integrative Medicine (IIIM), Jammu, organized a symposium on Day-III titled, ‘drug discovery in hybrid mode’.
Dr. Sunil Kumar Dubey, General Manager, Medical Research, R&D Healthcare Division Emami Ltd. Kolkata was the chief guest in the inaugural session and delivered a plenary lecture on "Pharmacokinetic Pharmacodynamic Modelling and Simulation of Phytopharmaceuticals."
He shared his expertise in using pharmacokinetic and pharmacodynamic modeling and simulation to understand the behavior of phytopharmaceuticals in the body and to design new drugs.
Further he dealt in detail about the various aspects of pre-clinical drug development from new chemical entities (NCE) and phytopharmaceuticals.
Lauding the role of CSIR-IIIM, Jammu in the drug development from natural resources, he emphasized that while developing phytopharmaceutical as drug, we need to make actual costing involved and the availability of standardized raw material.
Earlier, Dr. Zabeer Ahmed, Director CSIR-IIIM Jammu in his welcome address, introduced the chief guest among the audience and described Dr. Dubey as an acclaimed scientist having more than 16 years’ experience of teaching, research and administration.
He is among ‘World’s Top 2% Most-Cited Scientists’ as per the Elsevier-Stanford University report, added Dr. Ahmed.
Director, CSIR-IIIM also highlighted the institute's achievements and vision in drug discovery and integrative medicine.
